Clinical trials recruiting in Nadiād, India

Phase breakdown

Conditions recruiting in Nadiād, India

Recruiting trials in Nadiād, India

• A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
  NCT05348876 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
  NCT06676384 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Nadiād, India?

3 recruiting trials have at least one study site in Nadiād, India.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.